These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 16885555)
1. ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond. Sperling MA N Engl J Med; 2006 Aug; 355(5):507-10. PubMed ID: 16885555 [No Abstract] [Full Text] [Related]
2. Paediatric diabetes--which children can gain insulin independence? Srinivasan S; Donaghue KC Med J Aust; 2007 May; 186(9):436-7. PubMed ID: 17484702 [No Abstract] [Full Text] [Related]
3. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549 [TBL] [Abstract][Full Text] [Related]
4. Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation. Zwaveling-Soonawala N; Hagebeuk EE; Slingerland AS; Ris-Stalpers C; Vulsma T; van Trotsenburg AS Diabetologia; 2011 Feb; 54(2):469-71. PubMed ID: 21109997 [No Abstract] [Full Text] [Related]
5. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. Pearson ER; Flechtner I; Njølstad PR; Malecki MT; Flanagan SE; Larkin B; Ashcroft FM; Klimes I; Codner E; Iotova V; Slingerland AS; Shield J; Robert JJ; Holst JJ; Clark PM; Ellard S; Søvik O; Polak M; Hattersley AT; N Engl J Med; 2006 Aug; 355(5):467-77. PubMed ID: 16885550 [TBL] [Abstract][Full Text] [Related]
6. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene. Oztekin O; Durmaz E; Kalay S; Flanagan SE; Ellard S; Bircan I J Perinatol; 2012 Aug; 32(8):645-7. PubMed ID: 22842804 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. Stanik J; Gasperikova D; Paskova M; Barak L; Javorkova J; Jancova E; Ciljakova M; Hlava P; Michalek J; Flanagan SE; Pearson E; Hattersley AT; Ellard S; Klimes I J Clin Endocrinol Metab; 2007 Apr; 92(4):1276-82. PubMed ID: 17213273 [TBL] [Abstract][Full Text] [Related]
8. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes. Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376 [TBL] [Abstract][Full Text] [Related]
9. Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure. Pratt EB; Yan FF; Gay JW; Stanley CA; Shyng SL J Biol Chem; 2009 Mar; 284(12):7951-9. PubMed ID: 19151370 [TBL] [Abstract][Full Text] [Related]
10. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation. Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677 [TBL] [Abstract][Full Text] [Related]
11. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation. Ješić MM; Ješić MD; Maglajlić S; Sajić S; Necić S Diabetes Res Clin Pract; 2011 Jan; 91(1):e1-3. PubMed ID: 21056492 [TBL] [Abstract][Full Text] [Related]
12. K(ATP) channel pharmacogenomics: from bench to bedside. Sattiraju S; Reyes S; Kane GC; Terzic A Clin Pharmacol Ther; 2008 Feb; 83(2):354-7. PubMed ID: 17957187 [TBL] [Abstract][Full Text] [Related]
13. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Greeley SA; Naylor RN; Philipson LH; Bell GI Curr Diab Rep; 2011 Dec; 11(6):519-32. PubMed ID: 21993633 [TBL] [Abstract][Full Text] [Related]
14. A pathway to insulin independence in newborns and infants with diabetes. Shahawy S; Chan NK; Ellard S; Young E; Shahawy H; Mace J; Peverini R; Chinnock R; Njolstad PR; Hattersley AT; Hathout E J Perinatol; 2011 Aug; 31(8):567-70. PubMed ID: 21796147 [TBL] [Abstract][Full Text] [Related]
15. [Permanent neonatal diabetes with known genetic background: oral drugs in treatment of childhood diabetes]. Gach A; Gadzicka A; Młynarski W Pediatr Endocrinol Diabetes Metab; 2008; 14(1):45-9. PubMed ID: 18577347 [TBL] [Abstract][Full Text] [Related]